Updates are available Correction dated 2024-12-09
Click to view Correction: https://doi.org/10.1038/s41467-024-55167-0
-
Authors
Jang, Seonmi https://orcid.org/0009-0005-7668-9443
Yoo, Chaerim https://orcid.org/0009-0008-3206-6289
Kim, Hyung Shik
Kim, Jiyun
Lee, Dong Yun https://orcid.org/0000-0001-7691-0447
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2020R1A2C3005834, NRF-2022R1A4A1030421)
Korean Fund for Regenerative Medicine (KFRM) National Research Foundation of Korea
- License Information
-
More Information
Article History
Received: 22 March 2024
Accepted: 7 October 2024
First Online: 23 October 2024
Change Date: 9 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-55167-0
Competing interests
: Dong Yun Lee reports a relationship with Elixir Pharmatech Inc. that includes: board membership and equity or stocks. The remaining authors declare no competing interests.
